2019-2023 COVID-19 Pandemic

Public Health Emergency of International Concern (PHEIC)

In December 2019, WHO received reports of an unknown respiratory illness in China, found in January 2020 to be caused by a novel coronavirus. It quickly spread to other countries in east Asia and the WHO declared the outbreak a PHEIC on January 30, 2020. By March 2020, cases had been confirmed in most of Europe, Asia, and the Americas. Mitigation measures included widespread lockdowns, mass gathering restrictions, travel restrictions, and the use of face masks. There were also significant efforts to disburse resources and funding to assist healthcare facilities, businesses, and individuals most impacted by the pandemic. Various vaccines were developed at an unprecedented pace, with the first mass vaccination efforts in Europe and the US beginning in December 2020. The WHO declared an end to the PHEIC on May 5, 2023, while emphasizing that COVID-19 remains a global health threat. The WHO announced a review committee to develop recommendations as countries transition from emergency response to long-term management of COVID-19 alongside other diseases.

Total cases

680,000,000

Total deaths

6,900,000

Pathogen

SARS-CoV-2

Transmission

Human-to-human

Route of infection

Airborne, Direct contact, and Droplet

Medical countermeasures

Available at onset

None

Developed during or after event

Diagnostic tests, Treatments (antibiotics; antivirals), and Vaccines

Funding totals

Total funds disbursed and received globally for initiatives specific to this PHEIC.

Funds disbursed2020 - 2023

$55BTotal funding (USD)

Funds received2020 - 2023

$40BTotal funding (USD)

Top funders and recipients

Top 10 funders that disbursed PHEIC-specific funding, and top 10 recipients that received PHEIC-specific funding.